Aytu BioPharma, Inc. (AYTU)

Aytu BioPharma Analyst Ratings

• Total Analysts: 3
• Consensus Rating: Strong Buy
• Price Target: $9.33
• Upside: +261.63%

Ratings History

Filter results

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Edward Woo Ascendiant Capital	Ascendiant Capital	Strong Buy Maintains $13 → $13	Strong Buy	Maintains	$13 → $13	+403.88%	Dec 10, 2025
Naz Rahman Maxim Group	Maxim Group	Strong Buy Maintains $9 → $7	Strong Buy	Maintains	$9 → $7	+171.32%	Sep 25, 2025
Edward Woo Ascendiant Capital	Ascendiant Capital	Strong Buy Maintains $12 → $13	Strong Buy	Maintains	$12 → $13	+384.50%	Sep 25, 2025
Thomas Flaten Lake Street	Lake Street	Strong Buy Initiates $8	Strong Buy	Initiates	$8	+210.08%	Jul 1, 2025
Edward Woo Ascendiant Capital	Ascendiant Capital	Strong Buy Initiates $12	Strong Buy	Initiates	$12	+365.12%	Jun 30, 2025
Naz Rahman Maxim Group	Maxim Group	Strong Buy Initiates $5	Strong Buy	Initiates	$5	+93.80%	Aug 9, 2023
Vernon Bernardino HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $20	Strong Buy	Reiterates	$20	+675.19%	May 31, 2023
Vernon Bernardino HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $220 → $120	Strong Buy	Maintains	$220 → $120	+4,551.16%	Jul 21, 2022
Jennifer Kim Cantor Fitzgerald	Cantor Fitzgerald	Buy Maintains $220 → $100	Buy	Maintains	$220 → $100	+3,775.97%	May 17, 2022
Vernon Bernardino HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $480 → $220	Strong Buy	Maintains	$480 → $220	+8,427.13%	Apr 28, 2022
Jennifer Kim Cantor Fitzgerald	Cantor Fitzgerald	Buy Initiates $220	Buy	Initiates	$220	+8,427.13%	Mar 30, 2021
Vernon Bernardino HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Initiates $600	Strong Buy	Initiates	$600	+23,155.81%	May 29, 2020
Carl Byrnes Northland Capital Markets	Northland Capital Markets	Buy Initiates $2,000	Buy	Initiates	$2,000	+77,419.38%	Oct 22, 2018